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ABSTRACT  
The short-wavelength (blue) light sensitivity of human non-visual responses is recognised as 
being melanopsin-based.  However, whether melanopsin is the sole factor in determining the 
efficacy of a polychromatic light source in driving non-visual responses remains to be 
established.  Monochromatic (λmax 437, 479 and 532 nm) and polychromatic (colour 
temperature: 4000 K and 17000 K) light stimuli were photon matched for their predicted 
ability to stimulate melanopsin, and their capacity to affect nocturnal melatonin levels, 
auditory reaction time and subjective alertness and mood was assessed.   
 
Young, healthy male participants aged 18 – 35 years (23.6 ± 3.6 yrs; mean ± SD; n = 12) 
participated in 12 overnight sessions that included an individually timed 30 min light 
stimulus on the rising limb of the melatonin profile.  At regular intervals before, during and 
after the light stimulus subjective mood and alertness were verbally assessed, blood samples 
were taken for analysis of plasma melatonin levels and an auditory reaction time task 
(psychomotor vigilance task: PVT) was performed.  Proc GLM repeated measures ANOVA 
analysis revealed that significantly lower melatonin suppression was observed with the 
polychromatic light conditions (4000 K and 17000 K) compared to the ‘melanopsin photon-
matched’ monochromatic light conditions (p < 0.05).  In contrast, whilst subjective alertness 
significantly increased across the course of the light exposure it was significantly lower under 
the 479 nm monochromatic light condition compared to the 437 and 532 nm monochromatic 
and both polychromatic light conditions. 
 
The demonstration that the melatonin suppression response to polychromatic light was 
significantly lower than predicted by the melanopsin photosensitivity function suggests that 
this function is not the sole consideration when trying to predict the efficacy of broadband 
lighting.  The different spectral sensitivity of the subjective alertness and melatonin 
suppression responses may imply a differential involvement of the cone photopigments.  An 
analysis of the photon densities in specific wavelength bands for the polychromatic lights 
used in this and our previous study suggests that the spectral composition of a polychromatic 
light source, and particularly the very short wavelength content, may be critical in 
determining response magnitude for the non-visual effects of nocturnal light. 
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INTRODUCTION 
Non-visual responses to light in humans are short-wavelength (blue light) sensitive (Brainard 
et al., 2001; Thapan et al., 2001; Lockley et al., 2003; Cajochen et al., 2005; Revell et al., 
2005; Lockley et al., 2006; Revell et al., 2006) and this is attributed to the melanopsin 
photopigment that is expressed in the photosensitive retinal ganglion cells (pRGCs)  
(Provencio et al., 2000; Gooley et al., 2001; Berson et al., 2002).  Work in transgenic mice 
has demonstrated that whilst melanopsin-pRGCS are sufficient to sustain non-visual 
responses to light (Lucas et al., 2001; Hattar et al., 2003) it appears that both the rod and cone 
visual photopigments also contribute (Ruby et al., 2002; Lucas et al., 2003) primarily via the 
pRGCs (Guler et al., 2008).   The relative contribution of rods, cones and melanopsin to non-
visual responses appears to be context dependent and varies with the nature of the light 
stimulus (Lall et al., 2010).   
 
Lighting in industrial, clinical and home environments needs to optimally stimulate both the 
visual and non-visual systems and hence, broadband (400 – 700 nm) polychromatic lighting 
is appropriate.  However, to date, lighting has not been optimised for the non-visual system 
and this will likely be a highly complex procedure.  Firstly, it has been demonstrated, via 
physiological and behavioural studies in transgenic mice lacking specific photopigments, that 
the three photopigment classes contribute differentially to different non-visual responses 
(Lucas et al., 2003; Altimus et al., 2008; Lupi et al., 2008; Thompson et al., 2008; Tsai et al., 
2009; Lall et al., 2010).  Thus, optimal light for one situation/environment/population may 
not be effective or appropriate for another.  Secondly, there may be a time of day dependence 
to photopigment contribution (Tsai et al., 2009) which could reflect diurnal rhythms in retinal 
processing and/or gating of photopigment signals to the relevant brain areas.  Finally, 
melanopsin appears to be a bistable photopigment and can form stable associations with both 
11-cis (R, rhodopsin) and all-trans (M, metarhodopsin) isoforms of retinaldehyde and utilise 
light to transition between states.  Whilst the photosensitivity function (R → M) of 
melanopsin is most sensitive to short wavelength blue light the spectral sensitivity of the 
photoisomerase function (M → R) is currently unknown although both in vitro and in vivo 
studies implicate longer wavelengths (540 – 620 nm) (Melyan et al., 2005; Mure et al., 2007; 
Mure et al., 2009).  Such bistable properties of melanopsin may also influence non-visual 
responses to broadband lighting. 
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Previously we have demonstrated that the melatonin suppression response to an ultra high-
pressure mercury polychromatic light was significantly greater than would be predicted by a 
melanopsin photosensitivity function with λmax 480 nm (Revell and Skene, 2007).  We 
postulated that this unexpected effect could be due to a stimulatory effect of the wide range of 
wavelengths present in the polychromatic light source either via activation of the visual 
photopigments or the melanopsin photoisomerase function.  
 
The aim of the current study was to assess whether the melanopsin photosensitivity function 
(λmax 480 nm) could predict acute non-visual responses to monochromatic and polychromatic 
light with different spectral compositions.  It was hypothesised that if melanopsin was the 
sole contributor to nocturnal non-visual responses then light stimuli matched for melanopsin 
efficacy would produce the same magnitude responses.  Two polychromatic light sources 
(colour temperature: 4000 K and 17000 K) and three monochromatic lights, administered 
singly and in combination with 479 nm, were matched for predicted melanopsin efficacy and 
tested.  The monochromatic light conditions were chosen to be close to the wavelengths of 
maximal sensitivity of melanopsin (λmax 479 nm) and also the S-cones (λmax 437 nm) and the 
M-cones (λmax 532 nm) to try to discern any influence of these visual photopigments.   
 
METHODS 
Subjects 
Healthy male participants (n = 12) aged 18 – 35 years (23.6 ± 3.6 yrs; mean ± SD) completed 
12 overnight laboratory sessions in a within-subject, randomised, crossover design. 
Participants were non-smokers, free from drugs of abuse and prescription medication, and 
reported no medical disorders.  All participants underwent a full ophthalmic examination by a 
registered optician; participants were not colour blind and were free of ocular disorders.  
They had regular sleep schedules and reported no sleep disorders (Pittsburgh Sleep Quality 
Index ≤ 5).  All participants were neither morning nor evening types according to the Horne-
Östberg morningness-eveningness questionnaire (HÖ MEQ score: 50.9 ± 3.6).  The study 
was approved by the University of Surrey Ethics Committee and all participants gave written 
consent before the study began.  All procedures were conducted in accordance with the 
Declaration of Helsinki and conformed to international ethical standards (Portaluppi et al., 
2008).   
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Pre-study measurements 
From 10 days prior to the first in-laboratory session and for the duration of the study 
participants were required to maintain a strict sleep/wake schedule and regulate their alcohol, 
caffeine and non-steroidal-anti-inflammatory drug intake, similar to that previously described 
(Revell and Skene, 2007).  In addition, participants were also required to complete a 48 h 
urine collection (4 h collection periods, 8 h overnight) for measurement of the major urinary 
metabolite of melatonin, 6-sulphatoxymelatonin (aMT6s).  Cosinor analysis of the aMT6s 
rhythm was performed to determine the peak time of aMT6s production.  The light exposure 
was then individually timed to occur on the rising phase of the melatonin rhythm. 
 
In-laboratory protocol 
The protocol used was similar to that previously described (Thapan et al., 2001; Herljevic et 
al., 2005; Revell and Skene, 2007).  All participants completed 12 overnight in-laboratory 
sessions (19:00 – 07:00 h; October 2007 – April 2008) with a 2 h experimental period 
between 23:00 and 02:30 h.  Within this period there was a 30 min light exposure for 10 
sessions; the remaining two sessions were baseline, no-light conditions.  Data from two of the 
light conditions tested during this study protocol were not applicable to the hypotheses tested 
here and are thus not presented.  The sessions were run in blocks of three consecutive nights 
with blocks separated by at least four days.  Nights one and six were always no-light 
conditions and the ten light conditions were randomised amongst the remaining nights. 
 
Posture and environmental lighting were strictly controlled throughout each study session as 
previously described (Revell and Skene, 2007).  Blood samples were taken at 15 min 
intervals from 30 min before (-30) until 90 min after (90) the start of the light exposure for 
measurement of plasma melatonin levels by radioimmunoassay (Fraser et al., 1983).  
Participants were asked to verbally rate their mood and alertness levels at 15 min intervals 
from 15 min before (-15) until 45 min after (45) the start of the light exposure.  Subjective 
mood and alertness were assessed using the Karolinska Sleepiness Scale (KSS) (Akerstedt 
and Gillberg, 1990) and four 9 point mood and alertness scales (Revell et al., 2006; Lockley 
et al., 2008; Sletten et al., 2009).  A 10 min auditory test on a psychomotor vigilance task 
(PVT) monitor was utilised to assess reaction time before, during and after the light exposure.  
Auditory tests were scheduled to start 10 min before (-10), 20 min after (20) and 50 min after 
(50) the start of the light exposure.  The same protocol was conducted on all study sessions. 
 
 7
Light exposure 
Participants were administered pupil dilator (Minims Tropicamide 1.0%, Chauvin 
Pharmaceuticals, Romford, UK) in each eye 90 min before the start of the 30 min light 
exposure.  The light was administered using a sphere (45 cm diameter, Apollo Lighting, 
Leeds, UK) coated with a white reflectance paint (WRC-680 Labsphere, Pro-Lite 
Technology, Bedfordshire, UK).  For the monochromatic light conditions the spheres were 
illuminated with a fibre optic cable connected to an ultra high-pressure mercury lamp (Focus 
100LS3, 100 W, Philips Lighting, Eindhoven, The Netherlands).  For the two polychromatic 
light conditions the spheres were illuminated with specially housed fluorescent tubes with 
colour temperature of 17000 K or 4000 K (Philips Lighting). 
 
Light irradiances were measured with a calibrated radiometer (R203, Macam Photometrics 
Ltd., Livingston, Scotland) and the spectral distribution of the lights was measured with a 
calibrated spectrometer (Ocean Optics BV, Dunedin, Florida, USA).  The monochromatic 
light conditions were produced using narrow bandwidth interference filters (Coherent Ealing 
Europe Ltd., Watford, UK) with λmax 440, 480 and 535 nm (half maximal bandwidth λ0.5 10 
nm).  In situ λmax of the filters were shifted to 437, 479 and 532 nm, respectively.  The 
spectral power densities of the light conditions are shown in Figures 1a and 1b.  
 
Light conditions and calculations 
The parameters for each light condition are given in Table 1.  The predicted efficiency of the 
light stimulus to stimulate melanopsin was estimated as previously described (Revell and 
Skene, 2007).  Briefly, this was calculated as the number of effective photons integrated for 
wavelength and melanopsin spectral sensitivity, based on a Dartnall nomogram (Dartnall, 
1953) with λmax 480 nm.  The light conditions were matched so that they delivered the same 
number of ‘melanopsin-stimulating’ photons at the cornea although the total photon flux 
differed between light conditions.  The monochromatic and polychromatic light conditions 
were matched at 2.5 x 1013 ‘melanopsin-stimulating’ photons/cm2/sec whilst the combined 
monochromatic conditions were matched at 5.0 x 1013 ‘melanopsin-stimulating’ 
photons/cm2/sec.  In addition, the photon flux in 50 nm wavelength blocks was calculated for 
the light conditions used in the current study and for the polychromatic light used in our 
previous study (Revell and Skene, 2007) to provide assistance in interpretation of the results 
(Table 2).
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Table 1.  Irradiance and photon flux parameters for each of the light stimuli. 
Light condition ‘Melanopsin-stimulating’ 
photon density 
(photons/cm2/sec) 
Total photon density 
(photons/cm2/sec) 
Irradiance (µW/cm2) 
437 nm 2.5 x 1013 4.2 x 1013 19.1 
479 nm 2.5 x 1013 2.5 x 1013 10.4 
532 nm 2.5 x 1013 6.4 x 1013 23.8 
4000 K 2.5 x 1013 1.0 x 1014 36 
17000 K 2.5 x 1013 5.2 x 1013 20.3 
437 + 479 nm 2.5 x 1013 + 2.5 x 1013 6.7 x 1013 29.5 
479 + 479 nm 2.5 x 1013 + 2.5 x 1013 5.0 x 1013 20.8 
479 + 532 nm 2.5 x 1013 + 2.5 x 1013 8.9 x 1013 34.2 
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Table 2.  Photon flux in 50 nm wavelength blocks for the monochromatic and polychromatic light stimuli used in this and our previous study. 
 
 
 Photon flux (photons/cm2/sec) for 50 nm wavelength blocks 
Light  400 – 450 451 – 500 501 – 550 551 – 600 601 – 650 651 – 700 
437 nm 4.2 x 1013      
479 nm  2.5 x 1013     
532 nm   6.4 x 1013    
4000 K 8.9 x 1012 1.3 x 1013 2.8 x 1013 1.6 x 1013 3.2 x 1013 4.1 x 1012 
17000 K 9.1 x 1012 1.4 x 1013 1.6 x 1013 6.4 x 1012 7.4 x 1012  
High pressure 
mercury** 
 1.6 x 1013 9.6 x 1012 1.5 x 1013 2.6 x 1013 7.0 x 1012 1.1 x 1012 
 
**Revell and Skene, 2007
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Analysis and statistics  
Melatonin: Percentage melatonin suppression was calculated as the change in melatonin 
levels from 0 to 30 min as a percentage of the levels at 0 min.   
Mood and alertness: The scores at each time point (-15, 0, 15, 30 and 45 min) were 
individually normalised to the score at 0 min for each light condition.   
PVT: Tests were performed at three time points: ‘pre’, ‘during’ and ‘post’ light.  Six 
measurements were extracted for analysis: mean reaction time (RT), median RT, mean 
reciprocal reaction time (RRT), number of lapses > 400 ms, mean slowest RT, mean slowest 
RRT.   
 
Not all participants completed all light conditions: due to technical issues with the lights and 
problems with blood sampling one participant did not complete the 437 nm light condition, 
two participants did not complete the 17000 K light condition and two participants did not 
complete the 4000 K light condition.  Thus, a total of seven participants completed all eight 
light conditions.  Adequate melatonin profiles for analysis were obtained from 10 of the 12 
participants.   
 
All statistical analysis was carried out using Proc GLM repeated measures ANOVA analysis 
in the SAS program (SAS Institute Inc., Cary, NC, USA; Version 9.1).  This analysis 
accounted for any missing values in the data sets.  All analyses initially assessed whether 
there were any sequencing effects i.e. whether the study night significantly influenced the 
response.  Only outcome variables exhibiting no sequencing effects were considered for 
further analysis.  For the five ‘melanopsin photon-matched’ conditions, one-way repeated 
measures ANOVA analysis (factor: ‘light condition’) was conducted for the melatonin 
outcome variable and two-way repeated measures ANOVA analysis (factors: ‘light 
condition’ and ‘time’) was conducted for the PVT and normalised mood and alertness 
outcome variables.  As the no-light conditions occurred on fixed nights they were not 
included in the initial analysis.  However, for any parameters from the PVT and mood and 
alertness data that did not exhibit sequencing effects the ANOVA analysis was repeated to 
include a no-light condition (night 6).  For the combined monochromatic light conditions 
two-way repeated measures ANOVA analysis (factors: ‘light condition’ and ‘479 nm 
presence’) was conducted for the melatonin outcome variable and three-way repeated 
measures ANOVA analysis (factors: ‘light condition’, ‘479 nm presence’ and ’time’) was 
conducted for the PVT and normalised mood and alertness outcome variables to compare 
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437, 479 and 532 nm light with and without simultaneous presentation of 479 nm light.  For 
all analyses significant effects were followed up with post-hoc tests utilising least squares 
estimates of marginal means. 
 
RESULTS 
The ability of eight light conditions, matched for their predicted efficacy to stimulate 
melanopsin but differing in their total photon density, to influence nocturnal non-visual 
responses was assessed.   
 
Monochromatic and polychromatic lights matched for predicted melanopsin efficacy 
A significant effect of light condition on the degree of nocturnal melatonin suppression was 
observed (F (4, 31) = 5.98, p = 0.0011).  Post-hoc comparisons revealed that 437, 479 and 532 
nm light all induced significantly greater melatonin suppression than both 17000 K and  
4000 K light (p < 0.03) (Figure 2).  The degree of melatonin suppression did not appear to 
relate to the total photon content of the light stimulus; the lowest melatonin suppression was 
observed with the 4000 K light condition which had the highest total photon flux (1.0 x 1014 
photons/cm2/sec) and the greatest melatonin suppression was observed with the 437 nm light 
condition (4.2 x 1013 photons/cm2/sec).   
 
There was a significant effect of time (F (4, 236) = 4.84, p < 0.001) and light condition  
(F (4, 236) = 3.51, p < 0.01), but no significant light*time interaction, on subjective alertness.  
The level of alertness was significantly lower under the 479 nm light condition compared to 
the 437 nm, 532 nm, 4000 K and 17000 K conditions (p < 0.01).  When the analysis was 
repeated to include a no-light condition the significant effects of time (F (4, 299) = 4.33,  
p < 0.01) and light condition (F(5, 299) = 7.87, p < 0.0001) remained; both the no-light and  
479 nm light conditions exhibited significantly lower alertness levels than then remaining 
light conditions (p < 0.02); alertness under 479 nm light did not differ significantly from that 
under no-light (Figure 3).  Of the remaining subjective scales, two (KSS and cheerfulness) 
exhibited sequencing effects and two (calmness and depression) did not vary significantly 
with light condition or time.  Of the six PVT parameters measured, four of them exhibited 
sequencing effects and were not considered further.  The remaining two parameters (median 
RT and mean SRT) exhibited no significant time or light condition effects.  
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Monochromatic lights presented alone and simultaneously with 479 nm 
No significant effect of light condition, presence of 479 nm or light*479 nm presence 
interaction on melatonin suppression was observed (Figure 4).  Thus, for the 479 nm light 
condition, doubling the irradiance did not significantly alter the melatonin suppression 
response.  The PVT and subjective mood and alertness outcome variables exhibited either 
sequencing effects or no significant effects, with the exception of the KSS which exhibited a 
significant light*479 nm presence interaction. 
 
DISCUSSION  
The study aimed to determine whether the melanopsin photosensitivity function  
(λmax 480 nm) could predict the magnitude of non-visual responses to nocturnal light.  Thus, 
three monochromatic lights, administered singly and in combination with 479 nm, and two 
polychromatic lights of differing colour temperatures (4000 K and 17000 K) matched, for 
predicted melanopsin efficacy, were tested.  If melanopsin were the sole contributor to 
nocturnal non-visual light responses it was hypothesised that lights matched for melanopsin 
efficacy would produce the same magnitude responses.  
 
Indeed, for the monochromatic lights tested, no significant differences in the degree of 
melatonin suppression were observed amongst or between the single or the double intensity 
conditions.  The lack of a statistically significant irradiance effect for the 479 nm light 
conditions (single vs double) may reflect limited resolution of the melatonin response.  
However, our data are in agreement with the previously constructed irradiance response 
curves (IRC) for melatonin suppression (Thapan et al., 2001) which did not demonstrate any 
significant increase in suppression between photon densities similar to those used in the 
current study.   
 
The monochromatic light wavelengths were chosen to match the S-cone (437 nm) and M-
cone (532 nm) peak sensitivities to try to determine any influence of these photopigments in 
comparison to melanopsin alone (479 nm).  The lack of significant differences in melatonin 
suppression between the 437, 479 and 532 light conditions suggests either that the 
melanopsin photosensitivity function (λmax 480 nm) is predictive of response magnitude or 
that the melatonin suppression response does not have the sensitivity to detect different visual 
photopigment contributions.  The irradiances used in the current study were within the 
melanopsin operating range (> 1013 photons/cm2/sec) and thus, if melanopsin is the 
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predominant photopigment driving the response then it is possible that any additional 
influence of cones was not able to be detected.  Similar findings have been observed in mice 
whereby the magnitude of the pupil constriction response is accounted for solely by 
melanopsin once the light irradiance is within the melanopsin operating range and 
melanopsin is activated (Lucas et al., 2003) under a ‘winner takes all’ arrangement (Lall et 
al., 2010).  However, previous human studies using long duration nocturnal light stimuli of 
similar photon densities to those used here (2.8 x 1013 photons/cm2/sec) have implicated a 
role for cones in the melatonin suppression response (Lockley et al., 2003).  Very recently, 
dose response curves to 460 nm and 555 nm light for the melatonin suppression and phase 
delaying responses have been constructed in humans (Gooley et al., 2010).  Their findings 
demonstrated that cones can drive an initial melatonin suppression response but this is not 
sustained.  Further studies are required to fully understand the role and response dynamics of 
cones in human non-visual light responses.    
 
Even though photon matched for their ability to stimulate melanopsin both the 4000 K and 
17000 K lights exhibited significantly lower melatonin suppression compared to the 
monochromatic light conditions.  The fact that a simple photosensitivity function cannot 
solely determine the efficiency of a polychromatic light stimulus to suppress melatonin, 
however, may not be so surprising when the assumptions made to produce this prediction are 
considered.   Firstly, it is assumed that the calculated effective photon density is absorbed 
solely and entirely by melanopsin to generate a measurable physiological response.  
However, for a polychromatic light stimulus the photons across the visible light range are 
available for absorption not only by melanopsin but also by the rods and cones.  In addition, 
it is assumed that the photons are absorbed at a constant rate which may not be the case.  
Finally, the critical integration period over which melanopsin absorbs photons and drives 
specific responses is not known.  In a dynamic system there could be many factors at play 
and more information is needed before a full model can be generated that will allow the 
response to broadband lighting to be predicted.   
 
Our previous work also demonstrated that the response to polychromatic light cannot be 
predicted by a photosensitivity function with λmax 480 nm (Revell and Skene, 2007) but in 
that study the ultra high-pressure mercury lamp produced greater melatonin suppression than 
was predicted.  The discrepancy between our two studies may relate to the different spectra of 
the polychromatic light sources used.  A comparison of the photon flux in 50 nm wavelength 
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blocks for the polychromatic lights (Table 2) revealed the greatest difference between the 
ultra high-pressure mercury lamp and the 4000 K and 17000 K lights used in the current 
study occurred in the very short wavelength block (400 – 450 nm) and the medium 
wavelength block (551 – 600 nm).  The mercury lamp contained almost twofold the number 
of photons between 400 and 450 nm than the 4000 K or 17000 K lights.  In addition, in the 
551 – 600 nm block the mercury lamp contained four times the number of photons than the 
17000 K light and 60% more photons than the 4000 K light.  The increased photon flux in the 
551 – 600 nm range for the high pressure mercury lamp could enhance the melatonin 
suppression via stimulation of the M- and L- cones or via the photoreversal function of 
melanopsin as both in vitro and in vivo data have implicated 540 – 590  nm as being the 
optimal wavelength range for inducing the photoreversal of melanopsin (Melyan et al., 2005; 
Mure et al., 2007; Mure et al., 2009).  
 
The increased number of short wavelength photons in the high pressure mercury lamp 
combined with the fact that the greatest melatonin suppression in the current study occurred 
with the 437 nm light, suggests that the short wavelength content of the light stimulus may be 
a strong factor in determining the response magnitude.  This postulated sensitivity to short 
wavelength light could reflect either a role for the S-cones or that the photosensitivity 
function of human melanopsin is maximally sensitive to shorter wavelengths than the rodent 
data suggest.  Involvement of S-cones in human non-visual responses has previously been 
suggested (Thapan et al., 2001; Revell et al., 2006).  We demonstrated that the subjective 
alerting response to morning light was sensitive to very short wavelengths (420 nm) (Revell 
et al., 2006) and the high sensitivity of the melatonin suppression response to 424 nm light 
was suggested to reflect S-cone involvement (Thapan et al., 2001).  In addition, anatomical 
work in non-human primates has demonstrated that the S-cones exhibit a rare OFF response 
to the melanopsin-RGCs whereby they fire when the lights are turned off (Dacey et al., 
2005); the significance of this OFF signal, however, remains unclear.  Alternatively it is 
possible that the spectral sensitivity of human melanopsin may be different to rodent 
melanopsin.  The published melatonin suppression action spectra showed a λmax ~ 460 nm 
and the maximal melatonin suppression was observed at the 440 and 456 nm point, 
respectively (Brainard et al., 2001; Thapan et al., 2001) on non lens-corrected data.  In vitro 
expression of human melanopsin demonstrated an enhanced sensitivity to 420 nm compared 
to 480 nm (Melyan et al., 2005) which could not be reconciled with the animal data.  It was 
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thus postulated that this deviation may reflect an influence of the cell type used for the 
melanopsin expression work.  However, it is entirely possible that human melanopsin has a 
different spectral sensitivity to rodent melanopsin considering the nocturnal/diurnal 
differences between these species, the fact that different types of visual photopigments are 
expressed and that light can induce opposite effects e.g. sleep versus wake.   
 
The alerting effect of light at night observed in the current study supports previous work with 
both monochromatic and polychromatic light (Cajochen et al., 2000; Cajochen et al., 2005; 
Lockley et al., 2006; Revell et al., 2006; Sletten et al., 2009).  However, in contrast to the 
melatonin suppression data the alertness levels were significantly lower under the 479 nm 
light condition compared to the 437 nm, 532 nm, 4000 K and 17 000 K light conditions.  
Although this finding is at odds with previous studies demonstrating an enhanced alerting 
effect of 460 nm over 555 nm light (Lockley et al., 2006; Cajochen et al., 2005), differences 
in the study protocols could explain these discrepancies.  Firstly, the participants were awake 
for several hours before the light exposure (Lockley et al., 2006; Cajochen et al., 2005), 
compared to 30 min in our protocol, secondly, the lights were administered at different 
circadian phases: a) fixed clock time of 21:30 – 23:30 h (Cajochen et al., 2005), b) beginning 
~6.75 h before the core body temperature minimum (Lockley et al., 2006) and thirdly, the 
light exposures were for extended durations (2 or 6.5 h) compared to 30 min in our protocol.  
When a 6.5 h light stimulus was used (Lockley et al., 2006) after one hour of light exposure 
the alertness levels under 460 nm and 555 nm light do not appear to be significantly different 
suggesting that spectral differences to nocturnal light may only be observed under extended 
duration stimuli.  In the current study, the alerting efficacy of light appeared to relate to the 
total photon content of the stimulus as the effective light conditions had the highest 
irradiances.  Furthermore, the observed alerting effects of 437 nm and 532 nm light may 
implicate a role for cones in the alerting response to short duration light.  A contribution of 
cones to non-visual responses involving alerting/sleep centres over the first 30 min of a light 
stimulus has previously been demonstrated in mice (Altimus et al., 2008).   
  
In conclusion, the findings support our previous work (Revell and Skene, 2007) and 
demonstrate that the melanopsin photosensitivity function (λmax 480 nm) cannot predict non-
visual responses to polychromatic light.  Obviously, the current dataset has only assessed one 
‘melanopsin-stimulating’ photon density and complete fluence response curves to 
polychromatic light need to be constructed and compared to monochromatic light fluence 
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response curves to fully understand non-visual light responses.  Predicting non-visual 
responses to polychromatic light will likely be a complex procedure due to possible multiple 
photopigment involvement, the potential melanopsin photoreversal function, and the 
physiology and dynamics of both photon detection and signal processing.  Further work is 
required to determine these interactions and dynamics.   
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Figure Legends 
Figure1.  Spectral power density of a) monochromatic light conditions (λmax 437, 479 and 532 
nm) and b) polychromatic light conditions (colour temperature: ⎯ 4000 K and ----17000 K) 
as measured in situ with a calibrated spectrometer. 
 
Figure 2.  Percentage melatonin suppression (mean ± SEM) following a 30 min nocturnal 
light stimuli (2.5 x 1013 ‘melanopsin stimulating’ photons/cm2/sec) of monochromatic (437, 
479 and 532 nm) or polychromatic light (4000 K and 17000 K) matched for predicted 
melanopsin stimulation. * p < 0.05 compared to 437, 479 and 532 nm light.  
 
Figure 3.  Normalised subjective alertness (mean ± SEM) from 15 min before until 45 min 
after the start of a 30 min nocturnal light stimulus: ● no-light, ▲437 nm, ○ 479 nm, ■ 532 
nm, □ 17000 K and ?4000 K. 
 
Figure 4.  Percentage melatonin suppression (mean ± SEM) following a 30 min nocturnal 
light stimulus of  monochromatic 437, 479 and 532 nm light matched for predicted 
melanopsin stimulation: with (□ 5.0 x 1013 photons/cm2/sec) and without (? 2.5 x 1013 
photons/cm2/sec) simultaneous administration of 479 nm monochromatic light. 
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